Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes: a Multicenter, Randomized, Prospective, Open-label, Clinical Trial

NCT02312063 is registered in ClinicalTrials.gov with Kansai Electric Power Hospital as lead sponsor.

NCT NCT02312063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02312063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes: a Multicenter, Randomized, Prospective, Open-label, Clinical Trial
Lead sponsor
Kansai Electric Power Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2015
Completion date
May 31, 2016
Enrollment
48 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2